Accelerated hand bone mineral density loss is associated with progressive joint damage in hands and feet in recent-onset rheumatoid arthritis
- PMID: 20482894
- PMCID: PMC2911882
- DOI: 10.1186/ar3025
Accelerated hand bone mineral density loss is associated with progressive joint damage in hands and feet in recent-onset rheumatoid arthritis
Abstract
Introduction: To investigate whether accelerated hand bone mineral density (BMD) loss is associated with progressive joint damage in hands and feet in the first year of rheumatoid arthritis (RA) and whether it is an independent predictor of subsequent progressive total joint damage after 4 years.
Methods: In 256 recent-onset RA patients, baseline and 1-year hand BMD was measured in metacarpals 2-4 by digital X-ray radiogrammetry. Joint damage in hands and feet were scored in random order according to the Sharp-van der Heijde method at baseline and yearly up to 4 years.
Results: 68% of the patients had accelerated hand BMD loss (>-0.003 g/cm2) in the first year of RA. Hand BMD loss was associated with progressive joint damage after 1 year both in hands and feet with odds ratios (OR) (95% confidence intervals [CI]) of 5.3 (1.3-20.9) and 3.1 (1.0-9.7). In univariate analysis, hand BMD loss in the first year was a predictor of subsequent progressive total joint damage after 4 years with an OR (95% CI) of 3.1 (1.3-7.6). Multivariate analysis showed that only progressive joint damage in the first year and anti-citrullinated protein antibody positivity were independent predictors of long-term progressive joint damage.
Conclusions: In the first year of RA, accelerated hand BMD loss is associated with progressive joint damage in both hands and feet. Hand BMD loss in the first year of recent-onset RA predicts subsequent progressive total joint damage, however not independent of progressive joint damage in the first year.
Figures


Similar articles
-
Does digital X-ray radiogrammetry have a role in identifying patients at increased risk for joint destruction in early rheumatoid arthritis?Arthritis Res Ther. 2012 Oct 15;14(5):R219. doi: 10.1186/ar4058. Arthritis Res Ther. 2012. PMID: 23068060 Free PMC article.
-
Decrease in bone mineral density during three months after diagnosis of early rheumatoid arthritis measured by digital X-ray radiogrammetry predicts radiographic joint damage after one year.Arthritis Res Ther. 2017 Sep 2;19(1):195. doi: 10.1186/s13075-017-1403-0. Arthritis Res Ther. 2017. PMID: 28865482 Free PMC article.
-
Four-month metacarpal bone mineral density loss predicts radiological joint damage progression after 1 year in patients with early rheumatoid arthritis: exploratory analyses from the IMPROVED study.Ann Rheum Dis. 2015 Feb;74(2):341-6. doi: 10.1136/annrheumdis-2013-203749. Epub 2013 Nov 27. Ann Rheum Dis. 2015. PMID: 24285491 Clinical Trial.
-
Structural joint damage and hand bone loss in patients with rheumatoid arthritis.Dan Med J. 2018 Mar;65(3):B5452. Dan Med J. 2018. PMID: 29510810 Review.
-
Measuring metacarpal cortical bone by digital x-ray radiogrammetry: a step forward?Arthritis Res Ther. 2009;11(5):127. doi: 10.1186/ar2788. Epub 2009 Oct 1. Arthritis Res Ther. 2009. PMID: 19833006 Free PMC article. Review.
Cited by
-
Diagnostic accuracy of digital X-ray radiogrammetry on hand bone loss for patients with rheumatoid arthritis.Medicine (Baltimore). 2019 Sep;98(39):e17280. doi: 10.1097/MD.0000000000017280. Medicine (Baltimore). 2019. PMID: 31574843 Free PMC article.
-
A diagnostic model for assessing the risk of osteoporosis in patients with rheumatoid arthritis based on bone turnover markers.Arthritis Res Ther. 2025 Apr 1;27(1):75. doi: 10.1186/s13075-025-03544-5. Arthritis Res Ther. 2025. PMID: 40170112 Free PMC article.
-
Effects of dexamethasone, celecoxib, and methotrexate on the histology and metabolism of bone tissue in healthy Sprague Dawley rats.Clin Interv Aging. 2015 Aug 5;10:1245-53. doi: 10.2147/CIA.S85225. eCollection 2015. Clin Interv Aging. 2015. PMID: 26345380 Free PMC article.
-
Evaluation of hand bone loss by digital X-ray radiogrammetry as a complement to clinical and radiographic assessment in early rheumatoid arthritis: results from the SWEFOT trial.BMC Musculoskelet Disord. 2013 Mar 5;14:79. doi: 10.1186/1471-2474-14-79. BMC Musculoskelet Disord. 2013. PMID: 23497111 Free PMC article. Clinical Trial.
-
Risk of low bone mineral density in patients with rheumatoid arthritis treated with biologics.BMC Musculoskelet Disord. 2015 Sep 30;16:269. doi: 10.1186/s12891-015-0732-x. BMC Musculoskelet Disord. 2015. PMID: 26420629 Free PMC article.
References
-
- O'Gradaigh D, Ireland D, Compston JE. Joint erosion in rheumatoid arthritis: interactions between tumour necrosis factor alpha, interleukin 1, and receptor activator of nuclear factor kappaB ligand (RANKL) regulate osteoclasts. Ann Rheum Dis. 2004;63:354–359. doi: 10.1136/ard.2003.008458. - DOI - PMC - PubMed
-
- Ainola MM, Mandelin JA, Liljestrom MP, Li T-F, Hukkanen MVJ, Konttinen YT. Pannus invasion and cartilage degradation in rheumatoid arthritis: Involvement of MMP-3 and interleukin-1β. Clin Exp Rheumatol. 2005;23:644–650. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical